Neurology News

TeleSleep — a telehealth program offered by the Veterans Health Administration Office of Rural Health — improved access to care for sleep-related disorders, researchers reported.

Efgartigimod, a human IgG1 antibody designed to decrease pathogenic IgG autoantibody levels, demonstrated efficacy and tolerability among patients with generalized myasthenia gravis, according to findings published in The Lancet Neurology.

Total 1-year costs associated with intracerebral hemorrhage exceeded $120 million per year, according to results of a retrospective cohort study among adult patients in Ontario, Canada that were published in Neurology.

The FDA’s decision to approve Aduhelm represented one of the agency’s “most controversial [approvals] ever,” according to a piece published in the Ideas and Opinions section of Annals of Internal Medicine.

Two studies published in Annals of Neurology reported small clusters “of an unusual variant of Guillain-Barre syndrome” following receipt of a COVID-19 vaccine, according to a press release from the American Neurological Association.

The United States Supreme Court upheld the Affordable Care Act in a 7-2 vote.

Gerald E. Harmon, MD, was recently sworn in as the 176th president of the AMA.

An analysis of exome sequences in patients with ALS and healthy controls “strongly” indicated that variants in the TP73 gene are associated with risk for ALS, according to study results published in Neurology.

Certain acute treatments for episodic migraines improved pain and function, according to a systemic review and meta-analysis study published in JAMA.

The AMA said it has adopted new policies regarding the prior authorization process, with its outgoing president stating that maintaining the status quo may cause “life-or-death consequences.”